Ritlecitinib 1792180-81-4
4 Inquiries
1792180-81-4
shanghai
as request
2025-01-07
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
2-Propen-1-one, 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-
Other Name:PF-06651600;1792180-81-4;ritlecitinib;UNII-2OYE00PC25;1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one;2OYE00PC25;PF06651600;2-Propen-1-one, 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-;GTPL9559;PF-06651600 free base
CAS No.:1792180-81-4
Molecular Formula:C15H19N5O
InChIKeys:CBRJPFGIXUFMTM-WDEREUQCSA-N
Molecular Weight:285.34
Exact Mass:285.15896025
UNII:2OYE00PC25
NCI Thesaurus Code:C161783
Categories:
Characteristics -
-
Seller Information
-
Business Type:
Trader
-
Main Products:
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Location:
Room 1623,Building A, ZhongqiaoCenter,Goverment District,Hefei city,Anhui Province,China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2019
-
-
Inquiry History4 Inquiries
Country Product Purchase Quantity Date Posted 
United States
Ritlecitinib
1 MG Jun 6, 2025 
Canada
Ritlecitinib
100 G Nov 28, 2025 
India
RITLECITINIB
25.00 G May 7, 2025
India
RITLECITINIB
25.00 G Jul 1, 2025 Post an enquiry for this product